Drug Name: | Amantadine (768-94-5) |
---|---|
PubChem ID: | 2130 |
SMILES: | C1C2CC3CC1CC(C2)(C3)N |
InchiKey: | DKNWSYNQZKUICI-UHFFFAOYSA-N |
Therapeutic Category: | Analgesics, Anti-Dyskinesia Agents, Anti-Infective Agents, Antiparkinson Agents, Antiviral Agents, Central Nervous System Agents, Dopamine Agents, Neurotransmitter Agents, Peripheral Nervous System Agents, Sensory System Agents |
Molecular Weight (dalton) | : | 151.253 |
LogP | : | 1.9139 |
Ring Count | : | 0 |
Hydrogen Bond Acceptor Count | : | 1 |
Hydrogen Bond Donor Count | : | 1 |
Total Polar Surface Area | : | 26.02 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|---|---|---|---|
Hydrochlorothiazide (58-93-5) | Agitation | Synergistic | Uncertain | Amantadine-dyazide interaction |
Hydrochlorothiazide (58-93-5) | Ataxia | Synergistic | Uncertain | Amantadine-dyazide interaction |
Hydrochlorothiazide (58-93-5) | Hallucinations | Synergistic | Uncertain | Amantadine-dyazide interaction |
Phenelzine (51-71-8) | Rise In Blood Pressure | Synergistic | Uncertain | Possible interaction between pheneizine and amantadine |
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category